Helicobacter pylori (H. pylori) infection

Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taking low-dose aspirin or starting therapy with a non-steroidal anti-inflammatory medication, unexplained iron deficiency anemia, and idiopathic thrombocytopenic purpura. This American College of Gastroenterology guideline contains information about the diagnosis and management of patients with suspected or confirmed H. pylori infection. Details regarding the drugs, doses and duration of the recommended and suggested first-line and salvage regimens can be found in the guideline. This EvidenceCare Protocol is based on the American College of Gastroenterology 2017 publication “ACG Clinical Guideline: Treatment of Helicobacter pylori Infection”.

William Chey, MD
Read More

You May Also Like These Protocols

Lower GI Bleeding

This guideline provides recommendations for the management of patients with acute overt lower gastrointestinal bleeding. Hemodynamic status should be initially…

Learn More

Pulmonary Embolism (PE)

The diagnostic workup and proper treatment approach to patients with pulmonary embolism can be challenging. The EvidenceCare Pulmonary Embolism pathway…

Learn More